Edoxaban is an oral factor Xa inhibitor that prevents thrombin generation and platelet aggregation, and therefore thrombus formation.
Is rivaroxaban the best therapeutic option for this patient?
While price spikes in generic drugs have hurt retail pharmacies’ bottom lines, proposed U.S. legislation, negotiating with wholesalers, and other efforts may help even out prices in the future, pharmacy consultants said during a webinar late last week.
A new bedside delivery service of outpatient medications is being tested at an acute care facility in Cincinnati, Ohio.
The repercussions of antibiotic resistance are once again underscored in a recent policy brief from Health Affairs and the Robert Wood Johnson Foundation.
When it comes to patients with uncontrolled hypertension, those working with teams that include a pharmacist have better blood pressure control than those only working with doctors, according to research by the University of Iowa (UI).
Walgreens recently opened a retail pharmacy inside Our Lady of Lourdes Medical Center in Camden, N.J.
The good news is that the five-year relative survival rates for major cancers are rising. The bad news is that patient out-of-pocket costs associated with IV cancer drugs have also increased as physician-owned practices have been purchased by hospitals, according to a recent report from IMS Institute for Healthcare Informatics.
Secondary prevention of MI still calls for a careful balancing act between risks and benefits.
Last December, FDA granted accelerated approval to nivolumab for treatment of unresectable or metastatic melanoma in patients with cancer that no longer responds to other therapies.